|
|
|
|
LEADER |
02042nam a22005175i 4500 |
001 |
978-3-642-16499-6 |
003 |
DE-He213 |
005 |
20151204141444.0 |
007 |
cr nn 008mamaa |
008 |
110202s2011 gw | s |||| 0|eng d |
020 |
|
|
|a 9783642164996
|9 978-3-642-16499-6
|
024 |
7 |
|
|a 10.1007/978-3-642-16499-6
|2 doi
|
040 |
|
|
|d GrThAP
|
050 |
|
4 |
|a RM1-950
|
072 |
|
7 |
|a MMG
|2 bicssc
|
072 |
|
7 |
|a MED071000
|2 bisacsh
|
082 |
0 |
4 |
|a 615
|2 23
|
245 |
1 |
0 |
|a Urinary Tract
|h [electronic resource] /
|c edited by Karl-Erik Andersson, Martin C. Michel.
|
264 |
|
1 |
|a Berlin, Heidelberg :
|b Springer Berlin Heidelberg,
|c 2011.
|
300 |
|
|
|a XII, 580 p.
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a text file
|b PDF
|2 rda
|
490 |
1 |
|
|a Handbook of Experimental Pharmacology,
|x 0171-2004 ;
|v 2011
|
520 |
|
|
|a The basic anatomy and physiology of the urinary tract, the validity of animal models and other methodological considerations as well as a range of potential therapeutic targets are comprehensively reviewed by leading international experts, making this a unique reference source for basic scientists and research-minded clinicians alike.
|
650 |
|
0 |
|a Medicine.
|
650 |
|
0 |
|a Human physiology.
|
650 |
|
0 |
|a Molecular biology.
|
650 |
|
0 |
|a Pharmacology.
|
650 |
|
0 |
|a Urology.
|
650 |
1 |
4 |
|a Biomedicine.
|
650 |
2 |
4 |
|a Pharmacology/Toxicology.
|
650 |
2 |
4 |
|a Human Physiology.
|
650 |
2 |
4 |
|a Molecular Medicine.
|
650 |
2 |
4 |
|a Urology.
|
650 |
2 |
4 |
|a Biomedicine general.
|
700 |
1 |
|
|a Andersson, Karl-Erik.
|e editor.
|
700 |
1 |
|
|a Michel, Martin C.
|e editor.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|
776 |
0 |
8 |
|i Printed edition:
|z 9783642164989
|
830 |
|
0 |
|a Handbook of Experimental Pharmacology,
|x 0171-2004 ;
|v 2011
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1007/978-3-642-16499-6
|z Full Text via HEAL-Link
|
912 |
|
|
|a ZDB-2-SBL
|
950 |
|
|
|a Biomedical and Life Sciences (Springer-11642)
|